A subset analysis of a phase II trial evaluating the use of DFMO as maintenance therapy for high-risk neuroblastoma.
Int J Cancer
; 147(11): 3152-3159, 2020 12 01.
Article
in En
| MEDLINE
| ID: mdl-32391579
Full text:
1
Database:
MEDLINE
Main subject:
Eflornithine
/
Neuroblastoma
Type of study:
Etiology_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Child, preschool
/
Female
/
Humans
/
Male
Language:
En
Year:
2020
Type:
Article